Filter By Industry
Filter By Tag

Newsroom

Corporate Ads Press releases

1 - 6 of 6 Press Releases

Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
Sep 04, 2024
Genprex Stock Symbol: GNPX is Gene Therapy Focused on Life-Changing Developments for Cancer and Diabetes

Powerhouse Staffing Solutions Provider Completes Merger with Lyneer, Creating a Top 40 U.S. Staffing Firm: Atlantic Intl. Corp. (Stock Symbol: ATLN)
Aug 27, 2024
$ATLN Delivering Over $400 Million in Annual Revenue with 2025 Growth Projections Over $1 Billion

Popular China Based Amusement Park Operator Expands With Scenic Plot Deal for New Amusement Complex: Golden Heaven Group Holdings (Stock Symbol: GDHG)
Aug 27, 2024
GDHG operates amusement parks, water parks and complementary recreational facilities

Acquisition of Clinics Generating $100 Million to Complement Progress on Accelerated Drug Approval for Bipolar Depression NRx Pharmaceuticals: NRXP
Aug 26, 2024
NRXP: Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics.

Positive Clinical Results with Promising Gene Therapy Treatment for Late Stage Lung Cancer; Life-Changing Developments for Cancer & Diabetes: GNPX
Aug 21, 2024
Working With World-Class Institutions/Collaborators to Provide Novel Treatment Approaches. Stock Symbol: GNPX

Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: Nasdaq: NRXP
Aug 14, 2024
HOPE Therapeutic Subsidiary Focused on Developing a Best-in-Class Network of Clinics for Patients with Suicidal Depression and Related Disorders. HOPE is Planned to be Spun Out as a Separate Company to be Owned by NRXP Shareholders, and New Investors.


Corporate Ads RSS Feed